BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16201909)

  • 1. DNAzymes targeting the icl gene inhibit ICL expression and decrease Mycobacterium tuberculosis survival in macrophages.
    Li J; Zhu D; Yi Z; He Y; Chun Y; Liu Y; Li N
    Oligonucleotides; 2005; 15(3):215-22. PubMed ID: 16201909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effects of 10-23 deoxyribozyme targeting ICL gene on the expression of isocitrate lyase and the infection of Mycobacterium tuberculosis in macrophages].
    Li JM; Li N; Zhu DY; Yi ZJ; Liu YH; Yang C; He YL
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):531-5. PubMed ID: 17074266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
    McKinney JD; Höner zu Bentrup K; Muñoz-Elías EJ; Miczak A; Chen B; Chan WT; Swenson D; Sacchettini JC; Jacobs WR; Russell DG
    Nature; 2000 Aug; 406(6797):735-8. PubMed ID: 10963599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of isocitrate lyase from Mycobacterium tuberculosis on the survival of Mycobacterium smegmatis in macrophage and mechanism thereof].
    Li JM; Wan LG; Zhu DY; Li N; He YL; Yang C
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):551-4. PubMed ID: 18649772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis.
    Li JM; Li N; Zhu DY; Wan LG; He YL; Yang C
    Chin Med J (Engl); 2008 Jun; 121(12):1114-9. PubMed ID: 18706230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis.
    Nandakumar M; Nathan C; Rhee KY
    Nat Commun; 2014 Jun; 5():4306. PubMed ID: 24978671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.
    Muñoz-Elías EJ; McKinney JD
    Nat Med; 2005 Jun; 11(6):638-44. PubMed ID: 15895072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine succinylation of Mycobacterium tuberculosis isocitrate lyase (ICL) fine-tunes the microbial resistance to antibiotics.
    Zhou M; Xie L; Yang Z; Zhou J; Xie J
    J Biomol Struct Dyn; 2017 Apr; 35(5):1030-1041. PubMed ID: 27023679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular cloning, expression, purification and properties of isocitrate lyase gene from Mycobacterium tuberculosis H37Rv].
    Hao F; Pei XY; Zhang XL; Zhang SB; Lai XH; Wang HH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Dec; 28(12):845-8. PubMed ID: 16409788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary.
    Lee YV; Wahab HA; Choong YS
    Biomed Res Int; 2015; 2015():895453. PubMed ID: 25649791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹³C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation.
    Beste DJ; Bonde B; Hawkins N; Ward JL; Beale MH; Noack S; Nöh K; Kruger NJ; Ratcliffe RG; McFadden J
    PLoS Pathog; 2011 Jul; 7(7):e1002091. PubMed ID: 21814509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting isocitrate lyase for the treatment of latent tuberculosis.
    Bhusal RP; Bashiri G; Kwai BXC; Sperry J; Leung IKH
    Drug Discov Today; 2017 Jul; 22(7):1008-1016. PubMed ID: 28458043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of pyruvate-isoniazid analogs and their copper complexes as potential ICL inhibitors.
    Shingnapurkar D; Dandawate P; Anson CE; Powell AK; Afrasiabi Z; Sinn E; Pandit S; Venkateswara Swamy K; Franzblau S; Padhye S
    Bioorg Med Chem Lett; 2012 May; 22(9):3172-6. PubMed ID: 22475559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis.
    Ameeruddin NU; Luke Elizabeth H
    Tuberculosis (Edinb); 2014 Dec; 94(6):557-63. PubMed ID: 25270728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clone and expression of isocitrate lyase gene in Mycobacterium tuberculosis H37Rv].
    Li DW; Xiao CL; Guan Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):368-71. PubMed ID: 15379258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The six mammalian cell entry proteins (Mce3A-F) encoded by the mce3 operon are expressed during in vitro growth of Mycobacterium tuberculosis.
    Ahmad S; El-Shazly S; Mustafa AS; Al-Attiyah R
    Scand J Immunol; 2005 Jul; 62(1):16-24. PubMed ID: 16091122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid@Fe2 O3 Nanocontainers and Their Antibacterial Effect on Tuberculosis Mycobacteria.
    Leidinger P; Treptow J; Hagens K; Eich J; Zehethofer N; Schwudke D; Oehlmann W; Lünsdorf H; Goldmann O; Schaible UE; Dittmar KE; Feldmann C
    Angew Chem Int Ed Engl; 2015 Oct; 54(43):12597-601. PubMed ID: 26332072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase.
    Ibeji CU; Salleh NAM; Sum JS; Ch'ng ACW; Lim TS; Choong YS
    Sci Rep; 2020 Nov; 10(1):18925. PubMed ID: 33144641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiology. A weak link in TB bacterium is found.
    Helmuth L
    Science; 2000 Aug; 289(5482):1123-5. PubMed ID: 10970221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.